Characterization of ionotropic glutamate receptors in human lymphocytes
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The effect of L‐glutamate (Glu) on human lymphocyte function was studied by measuring anti‐CD 3 monoclonal antibody (mAb) or phytohaemagglutinin (PHA)‐induced intracellular Ca 2+ ([Ca 2+]i) rise (Fura‐2 method), and cell proliferation (MTT assay). Glu (0.001 – 100 μ M) did not modify basal lymphocyte [Ca 2+]i, but significantly potentiated the effects of anti‐CD 3 mAb or PHA. Maximal [Ca 2+]i rises over resting cells were: 165±8 and 247±10 n M at 3.0×10−2 mg ml−1 anti‐CD 3 mAb; 201±4 and 266±9 n M at 5.0×10−2 mg ml−1 PHA, in the absence or presence of 1 μ M Glu, respectively. The Glu effect showed a bell‐shape concentration‐dependent relationship, with a maximum (+90±3% for anti‐CD 3 mAb and +57±2% for PHA over Glu‐untreated cells) at 1 μ M. Non‐NMDA receptor agonists (1 μ M) showed a greater efficacy (+76±2% for (S)‐AMPA; +78±4% for KA), if compared to NMDA (+46±2%), or Glu itself. Ionotropic Glu receptor antagonists completely inhibited the effects of the corresponding specific receptor agonists (1 μ M). The IC 50 values calculated were: 0.9 μ M for D‐AP5; 0.6 μ M for (+)‐MK801; 0.3 μ M for NBQX. Both NBQX and KYNA were able to abolish Glu effect. The IC 50s calculated were: 3.4 μ M for NBQX; 0.4 μ M for KYNA. Glu (0.1 – 1 m M) did not change the resting cell proliferation, whereas Glu (1 m M) significant inhibited (−27±4%) PHA (1.0×10−2 mg ml−1)‐induced lymphocyte proliferation at 72 h. In conclusion, human lymphocytes express ionotropic Glu receptors functionally operating as modulators of cell activation. British Journal of Pharmacology (2001) 133, 936–944; doi:10.1038/sj.bjp.0704134
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · cited 1×
“…pharmacological properties compatible with ionotropic Glu receptors present on neuronal cells (Watkins & Evans, 1981; Collingridge & Lester, 1989; Dingledine et al., 1999): the prototype antagonists acting on these receptors block the Glu-evoked e ects on lymphocytes in a concentration-dependent…”
Background2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral Ischemia
Sheardown, M. J., Nielsen, E. Ø., Hansen, A. J., Jacobsen, P., & Honoré, T. (1990) · Science · doi:10.1126/science.2154034 · Cited by 1,138
Pathways and mechanisms for cytokine signaling of the central nervous system.
Licinio, J., & Wong, M. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119846 · Cited by 220 · cited 1×
“…molecules, such as proteases, oxygen radicals (Lucchesi, 1993; Ren et al., 1994; Ding et al., 1988), neurotoxins (Heyes et al., 1998), cytokines (Licinio & Wong, 1997), nitric oxide (Merrill et al., 1993; Boje, 1996), eicosanoids (Lucchesi, 1993; Morris & Rodger, 1998), and autoantibodies…”
Neuroimmunology of Alzheimer's disease: A conference report
Dickson, D. W., & Rogers, J. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90104-6 · Cited by 44 · cited 1×
“…1994), contributes to the outcome of acquired immunode®ciency syndrome (AIDS) (Koyanagi et al., 1987; Spencer & Price, 1993), Alzheimer's disease (AD) (Dickson & Rogers, 1992; Akiyama et al., 2000; Lim et al., 2000), and it is involved in epilepsy (Li et al., 1997) and multiple sclerosis (Pitt et…”
Background
Cited by
Beyond the role of glutamate as a neurotransmitter
Nedergaard, M., Takano, T., & Hansen, A. J. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn916 · Cited by 450
“, and that metabotropic glutamate receptor activation modulates calcium responses to antibodies in lymphocyte”
BackgroundMechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
Macrez, R., Stys, P. K., Vivien, D., Lipton, S. A., & Docagne, F. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30165-x · Cited by 127
Endogenous retroviral pathogenesis in lupus
Perl, A., Fernandez, D., Telarico, T., & Phillips, P. E. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833c6297 · Cited by 75
Regulation of the neurodegenerative process associated to Parkinson's disease by CD4+ T-cells
González, H., Contreras, F., & Pacheco, R. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9618-9 · Cited by 70
Metadata
- Authors
- Lombardi, G., Dianzani, C., Miglio, G., Canonico, P. L., & Fantozzi, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2001-07
- Volume
- 133
- Issue
- 6
- Pages
- 936-944
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1995032030
- Cited by
- 135
- References
- 5
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of ionotropic glutamate receptors in human lymphocytes. https://app.cochat.ai/papers/10.1038/sj.bjp.0704134
- The paper
- Lombardi, G., Dianzani, C., Miglio, G., Canonico, P. L., & Fantozzi, R. (2001). Characterization of ionotropic glutamate receptors in human lymphocytes. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0704134
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.